Cargando…
Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake...
Autores principales: | Tozer, G. M., Shaffi, K. M., Prise, V. E., Cunningham, V. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033701/ https://www.ncbi.nlm.nih.gov/pubmed/7981052 |
Ejemplares similares
-
Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites.
por: Sensky, P. L., et al.
Publicado: (1993) -
Modification of tumour blood flow using the hypertensive agent, angiotensin II.
por: Tozer, G. M., et al.
Publicado: (1993) -
The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.
por: Tozer, G. M., et al.
Publicado: (1995) -
Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.
por: Tozer, G. M., et al.
Publicado: (1996) -
The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
por: Cemazar, M, et al.
Publicado: (2005)